Should You Sell Neurobo Pharmaceuticals Inc (NRBO) Stock Friday Morning?

Neurobo Pharmaceuticals Inc (NRBO) has fallen Friday morning, with the stock decreasing -7.75% in pre-market trading to 1.19. NRBO's short-term technical score of 39 indicates that the stock has traded less bullishly over the last month than 61% of stocks on the market. In the Biotechnology industry, which ranks 133 out of 146 industries, the stock ranks higher than 56% of stocks. Neurobo Pharmaceuticals Inc has risen 7.50% over the past month, closing at $1.53 on November 25. During this period of time, the stock fell as low as $1.24 and as high as $2.33. NRBO has an average analyst recommendation of Strong Buy. The company has an average price target of $6.00.

NRBO has an Overall Score of 37. Find out what this means to you and get the rest of the rankings on NRBO!

See Full NRBO Report

Neurobo Pharmaceuticals Inc has a Long-Term Technical rank of 0. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 100% of the market scoring higher. In the Biotechnology industry which is number 126 by this metric, NRBO ranks better than 126% of stocks.

Important Dates for Investors in NRBO:

-Neurobo Pharmaceuticals Inc is set to release earnings on 2/12/2023. Over the last 12 months, the company has reported EPS of $-15.62. -We do not have a set dividend date for Neurobo Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Neurobo Pharmaceuticals Inc (NRBO)